{
    "code": "02025322",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025322",
    "time": "2022-01-28 06:07:50",
    "許可證字號": "衛署藥輸字第025322號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/01\/17",
    "發證\/登錄日期": "100\/01\/17",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202532200",
    "中文品名": "力復菲德注射劑",
    "英文品名": "LEVOPHED Injection",
    "適應症": "急性低血壓、心跳停止。",
    "劑型": "270注射劑",
    "包裝": "4毫升玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "NOREPINEPHRINE BITARTRATE (MONOHYDRATE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1212002015",
            "成分名稱": "NOREPINEPHRINE BITARTRATE (MONOHYDRATE)",
            "含量描述": "Each ml contains Norepinephrine Bitartrate 2.0mg, equivalent to Norepinephrine base 1.0mg",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Levophed vial label-109-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "HIL08-03力復菲德注射劑Levophed_USPI 201803-3_new add-110-08-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=006&Type=9"
        },
        {
            "title": "Levophed Injection-INS-080606-108-07-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=005&Type=9"
        },
        {
            "title": "Binder_Levophed inj_new add-110-04-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=004&Type=8"
        },
        {
            "title": "Levophed vial CTN-109-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=003&Type=8"
        },
        {
            "title": "Levophed Injection (Carton update)_20190527-108-05-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=002&Type=8"
        },
        {
            "title": "020253220007___20110414.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025322&Seq=001&Type=8"
        }
    ]
}